Eli Lilly Deal History & Licensing Activity

About Eli Lilly Licensing & Deal Activity

Eli Lilly is a large pharma company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 98 deals over the past three years, Eli Lilly ranks among the most acquisitive companies tracked by Ambrosia Ventures.

Key therapeutic areas of focus for Eli Lilly include Mega Deals (52 deals and trials), Oncology (19 deals and trials), Metabolic (15 deals and trials), and Neurology (10 deals and trials). In terms of modality, Eli Lilly has shown particular interest in vaccines, gene therapy, small molecules.

Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Eli Lilly and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Eli Lilly's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.